Search Results - "Refini, M"

Refine Results
  1. 1

    Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review by d'Alessandro, Miriana, Bergantini, Laura, Cameli, Paolo, Vietri, Lucia, Lanzarone, Nicola, Alonzi, Valerio, Pieroni, Maria, M Refini, Rosa, Sestini, Piersante, Bonella, Francesco, Bargagli, Elena

    Published in Biomarkers in medicine (01-06-2020)
    “…Interstitial lung diseases (ILD) are a group of lung disorders characterized by interstitial lung thickening. Krebs von den Lungen-6 (KL-6) is a molecule that…”
    Get full text
    Journal Article
  2. 2

    Serum Analysis of Coagulation Factors in IPF and NSIP by Bargagli, E., Madioni, C., Bianchi, N., Refini, R. M., Cappelli, R., Rottoli, P.

    Published in Inflammation (01-02-2014)
    “…Recent literature and our previous proteomic findings prompted us to study the coagulation system in idiopathic pulmonary fibrosis (IPF), the pathogenesis of…”
    Get full text
    Journal Article
  3. 3

    A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls by Landi, Claudia, Bargagli, Elena, Carleo, Alfonso, Bianchi, Laura, Gagliardi, Assunta, Prasse, Antje, Perari, Maria G., Refini, Rosa M., Bini, Luca, Rottoli, Paola

    Published in Proteomics. Clinical applications (01-12-2014)
    “…Background Idiopathic pulmonary fibrosis (IPF) is a devastating interstitial lung disease characterized by progressive loss of the alveolar integrity,…”
    Get full text
    Journal Article
  4. 4

    NK and NKT-like cells in granulomatous and fibrotic lung diseases by Bergantini, L, Cameli, P, d’Alessandro, M, Vagaggini, C, Refini, RM, Landi, C, Pieroni, MG, Spalletti, M, Sestini, P, Bargagli, E

    Published in Clinical and experimental medicine (01-11-2019)
    “…Abtract Background The pathogenetic and regulatory roles of natural killer (NK) and natural killer T-like cells in interstitial lung diseases (ILDs), fibrotic…”
    Get full text
    Journal Article
  5. 5

    Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies by Bergantini, L, Cameli, P, d’Alessandro, M, Vietri, L, Perruzza, M, Pieroni, M, Lanzarone, N, Refini, RM, Fossi, A, Bargagli, E

    Published in Inflammation (01-04-2020)
    “…Asthma is an immunoinflammatory disease characterized by bronchial hyper-reactivity to different external stimuli. New monoclonal target treatments have been…”
    Get full text
    Journal Article
  6. 6

    Calgranulin B (S100A9/MRP14): A Key Molecule in Idiopathic Pulmonary Fibrosis? by Bargagli, Elena, Olivieri, Carmela, Cintorino, Marcella, Refini, Rosa M., Bianchi, Nicola, Prasse, Antje, Rottoli, Paola

    Published in Inflammation (01-04-2011)
    “…Calgranulin B is a small calcium-binding protein with several immunological functions mainly involved in chronic inflammation and cancer. It can participate in…”
    Get full text
    Journal Article
  7. 7

    Exhaled nitric oxide and carbon monoxide in lung transplanted patients by Cameli, P, Bargagli, E, Fossi, A, Bennett, D, Voltolini, L, Refini, R.M, Gotti, G, Rottoli, P

    Published in Respiratory medicine (01-09-2015)
    “…Abstract Background Exhaled nitric oxide (eNO) and carbon monoxide (eCO) are markers of pulmonary inflammation associated with acute graft rejection and lung…”
    Get full text
    Journal Article
  8. 8

    Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma by Sestini, P, Armetti, L, Gambaro, G, Pieroni, M G, Refini, R M, Sala, A, Vaghi, A, Folco, G C, Bianco, S, Robuschi, M

    “…Bronchial overproduction of leukotrienes and inhibition of prostaglandin synthesis are involved in the pathogenesis of aspirin-induced asthma. We investigated…”
    Get more information
    Journal Article
  9. 9

    Prognostic bioindicators in severe COVID-19 patients by Bergantini, L., Bargagli, E., d'Alessandro, M., Refini, R.M., Cameli, P., Galasso, L., Scapellato, C., Montagnani, F., Scolletta, S., Franchi, F., Valente, S., Bennett, D., Sebastiani, G., Frediani, B., Dotta, F.

    Published in Cytokine (Philadelphia, Pa.) (01-05-2021)
    “…Severe acute respiratory syndrome caused by novel coronavirus 2 (SARS-CoV-2) emerged in Wuhan (China) in December 2019. Here we evaluated a panel of biomarkers…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions by Bianco, S, Pieroni, M G, Refini, R M, Rottoli, L, Sestini, P

    Published in The New England journal of medicine (19-10-1989)
    “…The movement of ions and water across the membranes of bronchial cells is part of the control of the bronchial obstructive response to physical stimuli. In a…”
    Get more information
    Journal Article
  12. 12

    A functional proteomics approach to the comprehension of sarcoidosis by Landi, C., Bargagli, E., Carleo, A., Bianchi, L., Gagliardi, A., Cillis, G., Perari, M.G., Refini, R.M., Prasse, A., Bini, L., Rottoli, P.

    Published in Journal of proteomics (14-10-2015)
    “…Pulmonary sarcoidosis (Sar) is an idiopathic disease histologically typified by non-caseating epitheliod cell sarcoid granulomas. A cohort of 37 Sar patients…”
    Get full text
    Journal Article
  13. 13

    Exhaled nitric oxide in interstitial lung diseases by Cameli, P, Bargagli, E, Refini, R.M, Pieroni, M.G, Bennett, D, Rottoli, P

    Published in Respiratory physiology & neurobiology (15-06-2014)
    “…Highlights • We measure exhaled NO levels in patients with idiopathic interstitial pneumonias. • Patients have higher levels of exhaled NO than healthy…”
    Get full text
    Journal Article
  14. 14

    Utility of spiral CAT scan in the follow-up of patients with pulmonary Langerhans cell histiocytosis by Abbritti, M, Mazzei, M.A, Bargagli, E, Refini, R.M, Penza, F, Perari, M.G, Volterrani, L, Rottoli, P

    Published in European journal of radiology (01-08-2012)
    “…Abstract Pulmonary Langerhans cell histiocytosis (PLCH) is a rare disease that occurs almost exclusively in smokers, generally young adults between 20 and 40…”
    Get full text
    Journal Article
  15. 15

    Pulmonary hypertension in idiopathic pulmonary fibrosis: prevalence and clinical progress by Castria, D, Refini, R M, Bargagli, E, Mezzasalma, F, Pierli, C, Rottoli, P

    “…The aims of the present study are to define the prevalence of pulmonary hypertension (PH) in a cohort of idiopathic pulmonary fibrosis (IPF) patients, to…”
    Get more information
    Journal Article
  16. 16

    Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin by BIANCO, S, ROBUSCHI, M, PETRIGNI, G, SCURI, M, PIERONI, M. G, REFINI, R. M, VAGHI, A, SESTINI, P. S

    Published in Drugs (Basel) (1993)
    “…Inflammation of the airways accompanied by eosinophil infiltration appears to play a fundamental role in the pathogenesis of bronchial asthma. Therefore,…”
    Get full text
    Conference Proceeding Journal Article
  17. 17

    Inhaled loop diuretics as potential new anti-asthmatic drugs by Bianco, S, Pieroni, M G, Refini, R M, Robuschi, M, Vaghi, A, Sestini, P

    Published in The European respiratory journal (01-01-1993)
    “…The observation that changes in bronchial osmolarity can induce bronchoconstriction in asthma inspired the experimental studies which, unexpectedly, revealed…”
    Get more information
    Journal Article
  18. 18

    Different Effects of Inhaled Aspirinlike Drugs on Allergen-Induced Early and Late Asthmatic Responses by SESTINI, PIERSANTE, REFINI, ROSA METELLA, PIERONI, MARIA GRAZIA, VAGHI, ADRIANO, ROBUSCHI, MARIA, BIANCO, SEBASTIANO

    “…Little is known about the anti-asthmatic effects of powerful anti-inflammatory agents such as aspirin-like drugs. We compared the effects of two aspirin-like…”
    Get full text
    Journal Article
  19. 19

    Time-limited protective effect of inhaled frusemide against aspirin-induced bronchoconstriction in aspirin-sensitive asthmatics by Sestini, P, Pieroni, MG, Refini, RM, Robuschi, M, Gambaro, G, Spagnotto, S, Vaghi, A, Bianco, S

    Published in The European respiratory journal (01-10-1994)
    “…Inhaled frusemide effectively prevents the bronchial obstructive response to allergens and to a number of nonallergic stimuli. In most of the experimental…”
    Get full text
    Journal Article
  20. 20

    Prevention of antigen-induced early obstructive reaction by inhaled furosemide in (atopic) subjects with asthma and (actively sensitized) guinea pigs by Robuschi, M, Pieroni, M, Refini, M, Bianco, S, Rossoni, G, Magni, F, Berti, F

    Published in Journal of allergy and clinical immunology (01-01-1990)
    “…The present study was undertaken to determine the effect of furosemide on antigen-induced bronchoconstriction. Ten patients with stable asthma (eight men and…”
    Get more information
    Journal Article